Tag: Dr. David Wohl

ViiV Healthcare secures Cabenuva FDA approval for HIV-1 treatment

pharmanewsdaily- January 24, 2021

Cabenuva FDA approval : ViiV Healthcare has secured approval from the US Food and Drug Administration (FDA) for its long-acting regimen Cabenuva for the treatment ... Read More